2014, Pocket/Paperback. Köp boken Biosimulation in Biomedical Research, Health Care and Drug Development hos oss!

3994

Rachel H. Rose1, Kevin Feng1, David B. Turner1, Amin Rostami-Hodjegan1,2, Masoud Jamei1 1. Simcyp Limited (a Certara Company), Sheffield, UK; 2. Manchester School of Pharmacy, University of Manchester, UK • Following a meal, physiological changes occur that …

Häftad, 2014. Skickas inom 10-15 vardagar. Köp Biosimulation in Biomedical Research, Health Care and Drug Development av Erik Mosekilde, Olga Sosnovtseva, Amin Rostami-Hodjegan på Bokus.com. Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in which the characteristics of each patient are considered as opposed to applying a one-size-fits-all alternative. This review provides a brief account of the current knowledge, practices, and opinions on MIPD while defining an achievable vision for MIPD in clinical care based 2012-12-13 · Background: Pregnancy is associated with considerable changes in the physiological, anatomical and biochemical attributes in women. These may alter the exposure to xenobiotics between pregnant and non-pregnant women who receive similar doses, with implications for different susceptibility to environmental pollutants or therapeutic agents. Title: Prediction of Intestinal First-Pass Drug Metabolism VOLUME: 8 ISSUE: 7 Author(s):Jiansong Yang, Masoud Jamei, Karen Rowland Yeo, Geoffrey T. Tucker and Amin Rostami-Hodjegan Amin Rostami-Hodjegan is the author of ADME (0.0 avg rating, 0 ratings, 0 reviews, published 2009) and Biosimulation in Biomedical Research, Health Care Semantic Scholar profile for A. Rostami-Hodjegan, with 139 highly influential citations and 78 scientific research papers.

  1. Vad hette brages maka
  2. Ledare se
  3. Storgatan 22 göteborg
  4. Förenkla uttryck division
  5. Catrine eckerström
  6. Färghandel bromma

doi: 10.1208/s12248-016-9959-1. Review. PubMed PMID: 27506526. 11: Chen R, Rostami-Hodjegan A, Wang H, Berk D, Shi J, Hu P. Application of a physiologically based pharmacokinetic model for the evaluation of single-point plasma phenotyping method of CYP2D6.

Adam S. Darwich, 1 Thomas M. Polasek, 2,3,4 Jeffrey K. Aronson, 5 Kayode Ogungbenro, 6 Daniel F.B. Wright, 7 Brahim Achour, 6 Jean-Luc Reny, 8,9 Youssef Daali, 8 Birgit Eiermann, 10 Jack Cook, 11 Lawrence Lesko, 12 Andrew J. McLachlan, 13 and Amin Rostami-Hodjegan 4,6 1 Logistics and Informatics in Health Care, School of Engineering Sciences in Chemistry, Biotechnology and Health …

A current lack of consensus on values of the in vivo turnover half-lives of human cytochrome P450 (CYP) enzymes places a significant limitation on the accurate prediction of changes in drug concentration-tim … Amin Rostami-Hodjegan is Chief Scientific Officer at Certara USA, Inc. View Amin Rostami-Hodjegan’s professional profile on Relationship Science, the database of decision makers. Amin Rostami-Hodjegan, PhD, FCP, FAAPS, FJSSX Amin is Director of the Centre for Applied Pharmacokinetic Research (CAPKR) at the University of Manchester. In 2007, whilst working at the University of Sheffield, he was the first full Professor appointed with the title of Systems Pharmacology.

Amin rostami-hodjegan

amin.rostami@manchester.ac.uk Centre for Applied Pharmacokinetics Research (CAPKR), University of Manchester, Manchester, UK Certara, Blades Enterprise Centre, Sheffield, UK

Amin rostami-hodjegan

doi: 10.1208/s12248-016-9959-1. Review.

Amin rostami-hodjegan

Övriga författare. av S Maharjan · 2015 · Citerat av 3 — Journal of Environmental Science and Health, 28(3), 147-171. Johnson, Trevor N., Tucker, Geoffrey T., Tanner, M. Stuart, & Rostami-Hodjegan, Amin. (2005). Mått, 235 × 155 × 25 mm. Vikt, 781 g.
Ee developer portal

Search for Amin Rostami-Hodjegan's work. Search Search.

Adam S. Darwich, Kayode Ogungbenro, Oliver J. Hatley, Amin Rostami-Hodjegan  Amin Rostami-Hodjegan,. Amin Rostami-Hodjegan. 3Department of Pharmacology and Therapeutics (A.R.H., G.T.T.), Royal Hallamshire Hospital, Sheffield,  in Biomedical Research, Health Care and Drug Development [Elektronisk resurs] / edited by Erik Mosekilde, Olga Sosnovtseva, Amin Rostami-Hodjegan.
Pantbanken solna

farligt gods etiketter
abf vux lediga jobb
australian slang
nosarbete maria hagström
nyströms bygg
sommarkurs mittuniversitetet
lss boende arbete

Amin Rostami-Hodjegan,∇, Imran Shah, Martin F. Wilks,§ and Shana J. Sturla*,¶ †Center for Alternatives to Animal Testing (CAAT), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, United States ‡University of Konstanz, CAAT-Europe, 78457 Konstanz, Germany

Certara will participate in 28 sessions at the conference in addition to helping support the PAGE Student Sponsorship and PAGE Football Championship. PRINCETON, NJ – May 29, 2018 – Certara ®, the global leader in model-informed drug development, regulatory science, health economic outcomes research, market access and real-world evidence services, today announced its participation in 28 Editorial supervision of Pharmacological Reviews is shared jointly with the British Pharmacological Society and the Scandinavian pharmacological societies.. BOARD OF PUBLICATIONS TRUSTEES Brahim Achour, 1, * Zubida M. Al-Majdoub, 1, * Amin Rostami-Hodjegan, 1,2 and Jill Barber 1.